Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026

Author:

Chapman Natalya1,Browning Michael23,Baghurst David14,Hotopf Matthew56,Willis Debbie7,Haylock Stuart1,Zakaria Sana1,Speechley Jan1,Withey James1,Brooks Edmund1,Chan Fiona1,Pappa Sofia89,Geddes John2,Insole Lisa10,Mohammed Zeid10,Kessler David11,Jones Peter B12,Mansoori Parisa4,

Affiliation:

1. National Institute for Health and Care Research Central Commissioning Facility, Twickenham, UK

2. Department of Psychiatry, University of Oxford, Oxford, UK

3. Oxford Health NHS Foundation Trust, Oxford, UK

4. National Institute for Health and Care Research Office for Clinical Research Infrastructure, Twickenham, UK

5. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK

6. South London and the Maudsley NHS Foundation Trust, London, UK

7. National Institute for Health and Care Research Evaluation, Trials and Studies Coordinating Centre, Southampton, UK

8. West London NHS Trust, London, UK

9. Department of Psychiatry, Imperial College London, London, UK

10. Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle, UK

11. Centre for Academic Mental Health, Bristol Medical School, University of Bristol, Bristol, UK

12. Department of Psychiatry, University of Cambridge, Cambridge and NIHR ARC East of England, Cambridgeshire & Peterborough NHS Foundation Trust, UK

Publisher

International Society of Global Health

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference59 articles.

1. Management of treatment-resistant depression in primary care: a mixed-methods study.;Wiles;Br J Gen Pract,2018

2. National Institute for Health & Clinical Excellence. Depression - The Treatment and Management of Depression in Adults (Updated Edition). In: National Clinical Practice Guideline 90 [Internet]. 2020. Available: https://www.nice.org.uk/guidance/cg90/evidence/full-guidline-pdf-4840934509. Accessed: 23 November 2021.

3. Prevalence and incidence studies of mood disorders: a systematic review of the literature.;Waraich;Can J Psychiatry,2004

4. World Health Organization. Depression and Other Common Mental Disorders Global Health Estimates. 2017. Available: http://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf;jsessionid=E2EC019EC8D79ED15D41FFDDD7CF5DB7?sequence=1. Accessed: 29 October 2021.

5. European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment of depression. European Medicines Agency. 2013. Available: www.ema.europa.eu. Accessed: 16 September 2021.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3